National Research logo

NRC - National Research Share Price

$50.03 -0.5  -0.9%

Last Trade - 18/09/20

Mid Cap
Market Cap £977.8m
Enterprise Value £993.8m
Revenue £100.7m
Position in Universe 2191st / 6396
Unlock NRC Revenue
Relative Strength (%)
1m -10.9%
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -29.9%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2014 2015 2016 2017 2018 2019 2020E 2021E CAGR / Avg
98.8 102.3 109.4 117.6 119.7 128 +5.3%
+17.3 -3.4 +16.1 +0.01 +29.0 +18.0
Balance Sheet
FINANCIAL BRIEF: : For the six months ended 30 June 2020, National Research Corporation revenues increased 3% to $65M. Net income applicable to common stockholders increased 25% to $19.4M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net income benefited from Other, net increase from $419K (expense) to $360K (income), Selling, General and Administrative - Ba decrease of 5% to $15M (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Latest News & Insights for NRC
Graphical History


NRC Revenue Unlock NRC Revenue

Net Income

NRC Net Income Unlock NRC Revenue

Normalised EPS

NRC Normalised EPS Unlock NRC Revenue

PE Ratio Range

NRC PE Ratio Range Unlock NRC Revenue

Dividend Yield Range

NRC Dividend Yield Range Unlock NRC Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
NRC EPS Forecasts Unlock NRC Revenue
Profile Summary

National Research Corporation, doing business as NRC Health, is a provider of analytics and insights for healthcare providers, payers and other healthcare organizations. The Company operates through six segments: Experience, The Governance Institute, Market Insights, Transparency, National Research Corporation Canada and Connect. The Company's portfolio of subscription-based solutions provides information and analysis to healthcare organizations and payers across a range of constituent-related elements, including patient experience and satisfaction, community population health risks, workforce engagement, community perceptions and physician engagement. NRC Health partners with clients across the range of healthcare services. The Company's clients range from integrated health systems and post-acute providers, such as home health, long-term care and hospice, to payer organizations. NRC Health's portfolio of solutions is designed to help healthcare companies.

Last Annual December 31st, 2019
Last Interim June 30th, 2020
Incorporated September 8, 1997
Public Since October 1, 1997
No. of Shareholders: 6,201
No. of Employees: 464
Sector Industrials
Industry Professional & Commercial Services
Index Nasdaq Composite ,
Exchange NASDAQ Global Select Market
Shares in Issue 25,241,049
Free Float (0.0%)
Eligible for
NRC Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for NRC
Upcoming Events for NRC
Tuesday 3rd November, 2020 Estimate
Q3 2020 National Research Corp Earnings Release
Tuesday 9th February, 2021 Estimate
Q4 2020 National Research Corp Earnings Release
Frequently Asked Questions for National Research
What is the National Research share price?

As of 18/09/20, shares in National Research are trading at $50.03, giving the company a market capitalisation of £977.8m. This share price information is delayed by 15 minutes.

How has the National Research share price performed this year?

Shares in National Research are currently trading at $50.03 and the price has moved by -20.8% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the National Research price has moved by -29.41% over the past year.

What are the analyst and broker recommendations for National Research?

Of the analysts with advisory recommendations for National Research, there are there are currently 0 "buy" , 1 "hold" and 0 "sell" recommendations. The overall consensus recommendation for National Research is Hold. You can view the full broker recommendation list by unlocking its StockReport.

When will National Research next release its financial results?

National Research is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-06-30
What is the National Research dividend yield?

The National Research dividend yield is 1.22% based on the trailing twelve month period.

Does National Research pay a dividend?

Last year, National Research paid a total dividend of 0.61, and it currently has a trailing dividend yield of 1.22%. Looking ahead, National Research has not announced an ex-dividend date yet.

When does National Research next pay dividends?

National Research has yet to annouce their ex-dividend date. The historic dividend yield on National Research shares is currently 1.22%.

How do I buy National Research shares?

To buy shares in National Research you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of National Research?

Shares in National Research are currently trading at $50.03, giving the company a market capitalisation of £977.8m.

Where are National Research shares listed? Where are National Research shares listed?

Here are the trading details for National Research:

Country of listing: United States
Exchange: NSQ
Ticker Symbol: NRC
What kind of share is National Research?

Based on an overall assessment of its quality, value and momentum, National Research is currently classified as a Falling Star. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a National Research share price forecast 2020?

We were not able to load any forecast data for National Research.

How can I tell whether the National Research share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like National Research. Over the past six months, the relative strength of its shares against the market has been -15.35%. At the current price of $50.03, shares in National Research are trading at -12.58% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the National Research PE Ratio?

The National Research PE ratio based on its reported earnings over the past 12 months is 35.55. The shares are currently trading at $50.03.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of National Research?

National Research's management team is headed by:

Michael Hays - CEO
John Nunnelly - LED
JoAnn Martin - IND
Kevin Karas - CFO
Steven Jackson - PRE
Donald Berwick - IND
Who are the major shareholders of National Research?

Here are the top five shareholders of National Research based on the size of their shareholding:

Amandla MK Trust Corporation
Percentage owned: 25.44% (6.42m shares)
K I E Trust Individual Investor
Percentage owned: 18.84% (4.76m shares)
Kayne Anderson Rudnick Investment Management, LLC Investment Advisor
Percentage owned: 12.47% (3.15m shares)
Virtus KAR Small-Cap Growth Fund Mutual Fund
Percentage owned: 9.55% (2.41m shares)
Neuberger Berman, LLC Investment Advisor/Hedge Fund
Percentage owned: 4.23% (1.07m shares)
Similar to NRC
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.